Sign In
Buy CGEN
$2.34
-0.0700 (-2.90%)
At Close: Aug 10, 2026
Compugen To Present New Insights into the Tumor Microenvironment Using Single Cell Spatial Transcriptomics at Keystone Symposium
07:00am, Monday, 14'th Mar 2022
HOLON, Israel , March 14, 2022 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced that it has
Compugen to Present at the Oppenheimer 32nd Annual Global Healthcare Conference
07:05am, Wednesday, 09'th Mar 2022
HOLON, Israel, March 9, 2022 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced that managem
5 Best Penny Stocks Under $5 To Buy According To Analysts Right Now
04:42pm, Friday, 25'th Feb 2022 PennyStocks
Today we look at five penny stocks to buy according to some of Wall Street's analyst firms.
The post 5 Best Penny Stocks Under $5 To Buy According To Analysts Right Now appeared first on Penny Stocks
5 Best Penny Stocks Under $5 To Buy According To Analysts Right Now
11:42am, Friday, 25'th Feb 2022
Today we look at five penny stocks to buy according to some of Wall Street's analyst firms. The post 5 Best Penny Stocks Under $5 To Buy According To Analysts Right Now appeared first on Penny Stocks
Compugen Ltd. (CGEN) CEO Anat Cohen-Dayag on Q4 2021 Results - Earnings Call Transcript
05:56pm, Thursday, 24'th Feb 2022 Seeking AlphaCompugen Ltd. (CGEN) CEO Anat Cohen-Dayag on Q4 2021 Results - Earnings Call Transcript
12:56pm, Thursday, 24'th Feb 2022
Compugen Ltd. (CGEN) CEO Anat Cohen-Dayag on Q4 2021 Results - Earnings Call Transcript
Compugen GAAP EPS of -$0.10 beats by $0.04
12:06pm, Thursday, 24'th Feb 2022 Seeking Alpha
Compugen press release (CGEN): Q4 GAAP EPS of -$0.10 beats by $0.04.As of December 31, 2021, cash, cash related accounts, short-term and long-term bank deposits totaled to…
Compugen Q4 2021 Earnings Preview
06:57pm, Wednesday, 23'rd Feb 2022 Seeking Alpha
Compugen (NASDAQ:CGEN) is scheduled to announce Q4 earnings results on Thursday, February 24th, before market open.The consensus EPS Estimate is -$0.13 (-30.0% Y/Y) and the…
Compugen to Release Fourth Quarter and Full Year 2021 Results on Thursday, February 24, 2022
12:00pm, Thursday, 10'th Feb 2022 PR Newswire
HOLON, Israel, Feb. 10, 2022 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, announced today that the Company will release its fourth quarter and full year 2021 financial results on Thursday, February
7 Penny Stocks To Buy Based On Cathie Wood’s ARK Invest Holdings
06:55pm, Wednesday, 09'th Feb 2022 PennyStocks
Cathie Wood stocks to watch right now.
The post 7 Penny Stocks To Buy Based On Cathie Wood’s ARK Invest Holdings appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
7 Penny Stocks To Buy Based On Cathie Wood's ARK Invest Holdings
01:55pm, Wednesday, 09'th Feb 2022
Cathie Wood stocks to watch right now. The post 7 Penny Stocks To Buy Based On Cathie Wood's ARK Invest Holdings appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Compugen to Present at the 11th Annual SVB Leerink Global Healthcare Conference
12:00pm, Wednesday, 09'th Feb 2022 PR Newswire
HOLON, Israel, Feb. 9, 2022 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today announced that management will present at the 11th Annual SVB Leerink Global Healthcare Conference (virtual), on…
Compugen to Present at the 11th Annual SVB Leerink Global Healthcare Conference
07:00am, Wednesday, 09'th Feb 2022
HOLON, Israel, Feb. 9, 2022 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today announced that management w
It's Time To Go To Cash For The Next 7 Years - 1-Year Update
07:41pm, Thursday, 20'th Jan 2022 Seeking Alpha
The stock market and bond market remain historically overvalued today, however, the almost all-encompassing bubble has started to break. Learn more here.
Zacks: Analysts Expect Compugen Ltd. (NASDAQ:CGEN) Will Post Earnings of -$0.15 Per Share
09:30pm, Saturday, 11'th Dec 2021 Dakota Financial News
Equities research analysts predict that Compugen Ltd. (NASDAQ:CGEN) will announce ($0.15) earnings per share (EPS) for the current fiscal quarter, according to Zacks Investment Research. Zero analysts have issued estimates for Compugens earnings. The lowest EPS estimate is ($0.16) and the highest is ($0.12). Compugen reported earnings per share of ($0.10) during the same quarter []
